Poxel SA: Poxel Provides Corporate Update and Reports Cash and Revenue for the First Quarter 2021
with product launch anticipated in 2021
1
Poxel regained Imeglimin rights from Metavant for US, Europe and other countries not covered by its agreement with Sumitomo Dainippon Pharma and is pursuing next steps to advance its development including partnering activities
Poxel continues to prepare for initiation of Phase 2b trial with PXL770 in patients with biopsy-proven NASH and pre-diabetes or type 2 diabetes, expected to commence in H2 2021
PXL065 Phase 2 study ongoing with completion of recruitment expected in mid-2021 and topline data readout in mid-2022
Imeglimin and PXL065 preclinical and clinical data published in peer reviewed journals; PXL770 data accepted for oral and poster presentations at an upcoming scientific conference
Poxel Provides Corporate Update and Reports Cash and Revenue for the First Quarter 2021
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
TodayIR: [2130 HK] CN Logistics Announces 1Q 2021 Results Revenue surged by 23 9% yoy to HKUSD 448 8 million together with Gross Profit increased by 31 0% to HKUSD 95 0 million
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
TodayIR: Tycoon-designated Placing Agent RaffAello Securities makes another move
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
(2) DJ EQS-News: Union Medical Healthcare expects full year sales volume in Mainland China to increase over 60% YoY & plans to open 6 new clinics and service centers in Shenzhen and Guangzhou by end of 2021 EQS-News / 20/04/2021 / 09:24 UTC+8 [FOR IMMEDIATE RELEASE] Union Medical Healthcare expects full year sales volume in Mainland China to increase over 60% YoY & plans to open 6 new clinics and service centers in Shenzhen and Guangzhou by end of 2021 (20 April 2021, Hong Kong) Union Medical Healthcare Limited ( Union Medical Healthcare or the Company , which together with its subsidiaries is referred to as the Group , SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong , is pleased to announce that in reference to the announcement dated 12 April 2021 which the Group expected to record an increase in sales volume in Mainland China of no less than 60% YoY for the year ended 31 March 2021. The Group wishes to further inform the Shareholders and pot